From: Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis
Patients: n = 19,538 Events: n = 2,700 | ||||
---|---|---|---|---|
HR | 95%-CI | p-value* | ||
Colon cancer | 0.0035 | |||
RPE only | 1 | |||
RT only | 1.326 | 0.970 | 1.813 | |
RT after RPE | 1.903 | 1.269 | 2.853 | |
Rectal cancer | 0.0077 | |||
RPE only | 1 | |||
RT only | 1.751 | 1.179 | 2.601 | |
RT after RPE | 0.638 | 0.278 | 1.465 | |
Lung cancer | 0.0011 | |||
RPE only | 1 | |||
RT only | 1.733 | 1.293 | 2.324 | |
RT after RPE | 1.017 | 0.598 | 1.730 | |
Bladder cancer | ||||
RPE only | 1 | <0.0001 | ||
RT only | 2.098 | 1.585 | 2.778 | |
RT after RPE | 1.601 | 1.001 | 2.561 | |
Non-melanoma skin cancer | ||||
RPE only | 1 | 0.0020 | ||
RT only | 1.658 | 1.246 | 2.205 | |
RT after RPE | 1.305 | 0.802 | 2.124 |